{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:02:07Z","timestamp":1790650927992,"version":"4.1.0"},"reference-count":129,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by either blocking translation or inducing degradation of target mRNA. miRNAs play essential roles in diverse biological and pathological processes, including development of hepatic fibrosis. Hepatic stellate cells (HSCs) play a central role in development of hepatic fibrosis and there are intricate regulatory effects of miRNAs on their activation, proliferation, collagen production, migration, and apoptosis. There are multiple differentially expressed miRNAs in activated HSCs, and in this review we aim to summarize current data on miRNAs that participate in the development of hepatic fibrosis. Based on this review, miRNAs may serve as biomarkers for diagnosis of liver disease, as well as markers of disease progression. Most importantly, dysregulated miRNAs may potentially be targeted by novel therapies to treat and reverse progression of hepatic fibrosis.<\/jats:p>","DOI":"10.3390\/jcm5030038","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T11:26:45Z","timestamp":1458127605000},"page":"38","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis"],"prefix":"10.3390","volume":"5","author":[{"given":"Mio","family":"Kitano","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Wexner Medical Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bloomston","sequence":"additional","affiliation":[{"name":"21st Century Oncology, 4571 Colonial Blvd., Suite 210, Fort Myers, FL 33966, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/sj.onc.1209909","article-title":"Principles and effects of microRNA-mediated post-transcriptional gene regulation","volume":"25","author":"Engels","year":"2006","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2010.09.019","article-title":"MicroRNAs, cancer and cancer stem cells","volume":"300","author":"Zimmerman","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_10","unstructured":"Homo Sapiens miRNAs. Available online: http:\/\/www.mirbase.org\/cgi-bin\/mirna_summary.pl?org=hsa."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/sj.onc.1209912","article-title":"MiRNAs and apoptosis: RNAs to die for","volume":"25","author":"Jovanovic","year":"2006","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2007.03.011","article-title":"Energizing miRNA research: A review of the role of miRNAs in lipid metabolism, with a prediction that miR-103\/107 regulates human metabolic pathways","volume":"91","author":"Wilfred","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","article-title":"A pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy","year":"2004","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physiolgenomics.00144.2007","article-title":"Altered microRNA expression in human heart disease","volume":"31","author":"Ikeda","year":"2007","journal-title":"Physiol. Genomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. microRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease","volume":"32","author":"Hebert","year":"2009","journal-title":"Trends Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_19","first-page":"414","article-title":"MicroRNAs in cancer treatment and prognosis","volume":"2","author":"Schoof","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nbt0408-400","article-title":"Cancer biomarker profiling with microRNAs","volume":"26","author":"Jeffrey","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_21","first-page":"33","article-title":"MicroRNA biogenesis: Isolation and characterization of the microprocessor complex","volume":"342","author":"Gregory","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/hepr.12386","article-title":"MiRNA in hepatocellular carcinoma","volume":"45","author":"Morishita","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2005.10.022","article-title":"Human RISC couples microRNA biogenesis and posttranscriptional gene silencing","volume":"123","author":"Gregory","year":"2005","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molcel.2012.05.012","article-title":"MicroRNA factory: RISC assembly from precursor microRNAs","volume":"46","author":"Kim","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1440-1746.2006.04584.x","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00795-003-0230-3","article-title":"Structure and function of hepatic stellate cells","volume":"37","author":"Senoo","year":"2004","journal-title":"Med. Electron. Microsc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00535-008-2180-y","article-title":"Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies","volume":"43","author":"Li","year":"2008","journal-title":"J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"G575","DOI":"10.1152\/ajpgi.00102.2006","article-title":"Evidence for epithelial-mesenchymal transitions in adult liver cells","volume":"291","author":"Sicklick","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2007-07-101261","article-title":"Hematopoietic origin of hepatic stellate cells in the adult liver","volume":"111","author":"Miyata","year":"2008","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2003.10.012","article-title":"Commitment of bone marrow cells to hepatic stellate cells in mouse","volume":"40","author":"Baba","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0016-5085(99)70407-5","article-title":"Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential","volume":"117","author":"Knittel","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: The nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/gut.48.4.548","article-title":"Apoptosis of hepatic stellate cells: Involvement in resolution of biliary fibrosis and regulation by soluble growth factors","volume":"48","author":"Issa","year":"2001","journal-title":"Gut"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3727\/105221614X13919976902057","article-title":"Hepatic fibrosis and the microenvironment: Fertile soil for hepatocellular carcinoma development","volume":"16","author":"Wallace","year":"2014","journal-title":"Gene Expr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1038\/srep16163","article-title":"MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a","volume":"5","author":"Du","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.trsl.2015.04.014","article-title":"High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis","volume":"166","author":"Leti","year":"2015","journal-title":"Transl. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1111\/j.1742-4658.2009.07213.x","article-title":"Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways","volume":"276","author":"Guo","year":"2009","journal-title":"FEBS J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"MiR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hep.25613","article-title":"Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis","volume":"56","author":"Lakner","year":"2012","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3748\/wjg.v17.i22.2748","article-title":"miRNA studies in in vitro and in vivo activated hepatic stellate cells","volume":"17","author":"Maubach","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., and Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016081"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2007.02.033","article-title":"Gene expression profiles during hepatic stellate cell activation in culture and in vivo","volume":"132","author":"Seki","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.3748\/wjg.v21.i34.9900","article-title":"MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1","volume":"21","author":"Qi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.2015.58","article-title":"MicroRNA-17\u20135p activates hepatic stellate cells through targeting of Smad7","volume":"95","author":"Yu","year":"2015","journal-title":"Lab Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","article-title":"The autoregulatory feedback loop of microRNA-21\/programmed cell death protein 4\/activation protein-1 (miR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhao, J., Tang, N., Wu, K., Dai, W., Ye, C., Shi, J., Zhang, J., Ning, B., Zeng, X., and Lin, Y. (2014). MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108005"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/CS20140012","article-title":"The role of miR-31\/FIH1 pathway in TGFbeta-induced liver fibrosis","volume":"129","author":"Hu","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellsig.2013.09.018","article-title":"Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells","volume":"26","author":"Li","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/mmr.2014.2846","article-title":"MicroRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor gamma","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.12659\/MSM.894000","article-title":"MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1","volume":"21","author":"Yan","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/dna.2014.2760","article-title":"Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-kappaB pathway","volume":"34","author":"Feng","year":"2015","journal-title":"DNA Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2015.08.012","article-title":"MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARgamma expression: A rat fibrosis model study","volume":"465","author":"Lu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1478-3231.2010.02433.x","article-title":"Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C","volume":"31","author":"Morita","year":"2011","journal-title":"Liver Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00140.2015","article-title":"Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: Role of exosomes in horizontal transfer of Twist1","volume":"309","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1755-1536-5-12","article-title":"Induction of microRNA-214-5p in human and rodent liver fibrosis","volume":"5","author":"Iizuka","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","article-title":"MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis","volume":"61","author":"Ogawa","year":"2012","journal-title":"Gut"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10495-009-0401-3","article-title":"Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells","volume":"14","author":"Guo","year":"2009","journal-title":"Apoptosis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/jcb.25116","article-title":"MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol","volume":"116","author":"Ge","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jir186","article-title":"Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: MiR-29 overexpression reduces hepatitis C viral abundance in culture","volume":"203","author":"Bandyopadhyay","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kwiecinski, M., Noetel, A., Elfimova, N., Trebicka, J., Schievenbusch, S., Strack, I., Molnar, L., von Brandenstein, M., T\u00f6x, U., and Nischt, R. (2011). Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024568"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/labinvest.2012.70","article-title":"Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29","volume":"92","author":"Kwiecinski","year":"2012","journal-title":"Lab Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","article-title":"Suppression of type I collagen production by microRNA-29b in cultured human stellate cells","volume":"391","author":"Ogawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Huang, Y.H., Tiao, M.M., Huang, L.T., Chuang, J.H., Kuo, K.C., Yang, Y.L., and Wang, F.S. (2015). Activation of miR-29a in activated hepatic stellate cells modulates its profibrogenic phenotype through inhibition of histone deacetylases 4. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136453"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10495-013-0909-4","article-title":"MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway","volume":"19","author":"Tiao","year":"2014","journal-title":"Apoptosis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbrc.2014.03.037","article-title":"MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase","volume":"446","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/febs.12574","article-title":"Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation\u2014A novel mechanism suppressing liver fibrosis","volume":"281","author":"Zheng","year":"2014","journal-title":"FEBS J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfv081","article-title":"MicroRNA-30 protect against CCl4-induced liver fibrosis by attenuating TGF-beta signaling in hepatic stellate cells","volume":"146","author":"Tu","year":"2015","journal-title":"Toxicol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.4373","article-title":"MicroRNA-101 suppresses liver fibrosis by targeting the TGF-beta signalling pathway","volume":"234","author":"Tu","year":"2014","journal-title":"J. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","article-title":"MiR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.18632\/oncotarget.3652","article-title":"Identification of a novel TGF-beta-miR-122-fibronectin 1\/serum response factor signaling cascade and its implication in hepatic fibrogenesis","volume":"6","author":"Zeng","year":"2015","journal-title":"Oncotarget"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.febslet.2013.09.047","article-title":"Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells","volume":"587","author":"Guo","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","article-title":"MiR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis","volume":"58","author":"Roderburg","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_81","first-page":"3994","article-title":"miR-144 regulates transforming growth factor-beta1 iduced hepatic stellate cell activation in human fibrotic liver","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","article-title":"MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4","volume":"24","author":"He","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","article-title":"Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation","volume":"298","author":"Venugopal","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/ijmm.2013.1356","article-title":"Activation of hepatic stellate cells is suppressed by microRNA-150","volume":"32","author":"Zheng","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/liv.12660","article-title":"MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway","volume":"35","author":"Dai","year":"2015","journal-title":"Liver Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/jcp.22598","article-title":"Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation","volume":"226","author":"Sekiya","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.cellsig.2014.07.016","article-title":"MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis","volume":"26","author":"Yang","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-013-1895-0","article-title":"Participation of miR-200a in TGF-beta1-mediated hepatic stellate cell activation","volume":"388","author":"Sun","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.26768","article-title":"Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.yexcr.2011.05.001","article-title":"Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation","volume":"317","author":"Chen","year":"2011","journal-title":"Exp. Cell Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s10620-015-3585-0","article-title":"MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened","volume":"60","author":"Lu","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1756-3305-7-148","article-title":"Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum","volume":"7","author":"Zhu","year":"2014","journal-title":"Parasit. Vectors"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jcmm.12293","article-title":"Overexpression of miR-483\u20135p\/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-beta stimulated HSCs in transgenic mice","volume":"18","author":"Li","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.18632\/oncotarget.2621","article-title":"MicroRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Mannaerts, I., Eysackers, N., Onyema, O.O., Van Beneden, K., Valente, S., Mai, A., Odenthal, M., and van Grunsven, L.A. (2013). Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055786"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2011.07.041","article-title":"Suppression of hepatic stellate cell activation by microRNA-29b","volume":"412","author":"Sekiya","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-014-2199-8","article-title":"Hepatic stellate cell is activated by microRNA-181b via PTEN\/Akt pathway","volume":"398","author":"Zheng","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3748\/wjg.v11.i17.2634","article-title":"Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibrosis","volume":"11","author":"Chang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12072-009-9129-y","article-title":"Effect of natural interferon alpha on proliferation and apoptosis of hepatic stellate cells","volume":"3","author":"Ogawa","year":"2009","journal-title":"Hepatol. Int."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2567.2007.02672.x","article-title":"Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects","volume":"122","author":"Tanabe","year":"2007","journal-title":"Immunology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/gast.2003.50012","article-title":"Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors","volume":"124","author":"Yang","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/mmr.2013.1866","article-title":"Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells","volume":"9","author":"Yu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/jcmm.12655","article-title":"Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation","volume":"19","author":"Yu","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Knabel, M.K., Ramachandran, K., Karhadkar, S., Hwang, H.W., Creamer, T.J., Chivukula, R.R., Sheikh, F., Clark, K.R., Torbenson, M., and Montgomery, R.A. (2015). Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124411"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/mol.110.068247","article-title":"Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells","volume":"80","author":"Li","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10620-009-1021-z","article-title":"Hepatic stellate cell-specific gene silencing induced by an artificial microRNA for antifibrosis in vitro","volume":"55","author":"Chang","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.12323","article-title":"3,3\u2032-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression","volume":"170","author":"Zhang","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11418-009-0347-3","article-title":"Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells","volume":"63","author":"Shu","year":"2009","journal-title":"J. Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"Newe Engl. J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2014.08.015","article-title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","volume":"111","author":"Maan","year":"2014","journal-title":"Antiviral Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids\u2014the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","article-title":"MiR-122 in hepatic function and liver diseases","volume":"3","author":"Hu","year":"2012","journal-title":"Protein Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/ajg.2011.161","article-title":"Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection","volume":"106","author":"Bihrer","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","article-title":"Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases","volume":"56","author":"Zhang","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4149\/neo_2013_018","article-title":"Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma","volume":"60","author":"Qi","year":"2013","journal-title":"Neoplasma"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis","volume":"58","author":"Trebicka","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbrc.2012.03.025","article-title":"miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients","volume":"421","author":"Wang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2014.07.017","article-title":"Circulating microRNAs as markers of liver inflammation, fibrosis and cancer","volume":"61","author":"Roderburg","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00535-014-0986-3","article-title":"MiR-33a levels in hepatic and serum after chronic HBV-induced fibrosis","volume":"50","author":"Huang","year":"2015","journal-title":"J. Gastroenterol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Jansen, C., Eischeid, H., Goertzen, J., Schierwagen, R., Anadol, E., Strassburg, C.P., Sauerbruch, T., Odenthal, M., and Trebicka, J. (2014). The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103779"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Jansen, C., Reiberger, T., Huang, J., Eischeid, H., Schierwagen, R., Mandorfer, M., Anadol, E., Schwabl, P., Schwarze-Zander, C., and Warnecke-Eberz, U. (2015). Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV\/HCV coinfection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116768"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.27369","article-title":"Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients","volume":"61","author":"Anadol","year":"2015","journal-title":"Hepatology"},{"key":"ref_128","unstructured":"Centers for Disease Control and Prevention Chronic Liver Disease and Cirrhosis, Available online: http:\/\/www.cdc.gov\/nchs\/fastats\/liver-disease.htm."},{"key":"ref_129","unstructured":"ClinicalTrials.Gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/results?term=microrna&Search=Search."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/5\/3\/38\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:46Z","timestamp":1760210446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/5\/3\/38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":129,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["jcm5030038"],"URL":"https:\/\/doi.org\/10.3390\/jcm5030038","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]}}}